Follow the 씨엑스아이 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 씨엑스아이 has published 42 public disclosures. Market capitalisation: €14.6bn. The latest transaction was reported on 16 March 2026 (Purchase). Among the most active insiders: LIN JINSHENG. The full history is openly available.
42
Insider Decl.
0
Thresholds
·
17 ops.
Buy Volume
·
2 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 348 of 26,282 companies
85.9
score / 100
Value
100
Quality
72
FCF yld·
Earn yld74%
EV/EBITDA0.7x
ROE1.6%
Gross mgn43%
Net mgn42%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.